Many cardiovascular risk factors such as diabetes mellitus, hypertension and hyperlipidemia are demonstrated to stimulate the interaction of Cav-1 and eNOS, reduce nitric oxide production resulting in endothelial dysfunction and subsequently the formation of atherosclerotic lesion 41,42,43
Moreover, it comes in capsule form, allowing accurate dosing and easy handling in laboratory research
BPC 157: PubChem CID: 9941957 PubChem SID: 329830514 CAS Number: 137525-51-0 TB 500: Molecular Formula: C212H350N56O78S CAS Number: 885340-08-9
All information regarding dosages, protocols, and applications is based on publicly available research and user reports, and may be inaccurate or incomplete
So, its like a more intense schedule at the beginning, and then it becomes less frequent over time